Joseph Pergolizzi
Principal investigator, leads ENALARE THERAPEUTICS INC.
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2022First federal award
$320KFederal grants as PI1 awards
1Patents grantedLatest Nov 12, 2024
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
1 awards · $320K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 1, 2022 | NIH | SBIR Phase I Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting. | $320K | ENALARE THERAPEUTICS INC |
2 patents as inventor
- US 12138267ENALARE THERAPEUTICS INCNov 12, 2024
- US ENALARE THERAPEUTICS INC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#2,857
Awards as PI#2,176
Patents#155
Companies
- ENALARE THERAPEUTICS INCLeads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.